In This Article:
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.
A lack of profits can lead to trouble, but StockStory helps you identify the businesses that stand a chance of making it through. That said, here are three unprofitable companiesto steer clear of and a few better alternatives.
AMC Networks (AMCX)
Trailing 12-Month GAAP Operating Margin: -3.6%
Originally the joint-venture of four cable television companies, AMC Networks (NASDAQ:AMCX) is a broadcaster producing a diverse range of television shows and movies.
Why Do We Pass on AMCX?
-
Annual sales declines of 4.6% for the past five years show its products and services struggled to connect with the market
-
Performance over the past five years shows each sale was less profitable as its earnings per share dropped by 15.3% annually, worse than its revenue
-
Shrinking returns on capital from an already weak position reveal that neither previous nor ongoing investments are yielding the desired results
AMC Networks’s stock price of $6.30 implies a valuation ratio of 2.1x forward P/E. To fully understand why you should be careful with AMCX, check out our full research report (it’s free).
Fluence Energy (FLNC)
Trailing 12-Month GAAP Operating Margin: -1.1%
Pioneering the use of lithium-ion batteries for grid storage, Fluence (NASDAQ:FLNC) helps store renewable energy sources with battery systems.
Why Do We Think Twice About FLNC?
-
Historically negative EPS casts doubt for cautious investors and clouds its long-term earnings prospects
-
Investments to defend its competitive moat have ramped up over the last five years as its free cash flow margin decreased by 12 percentage points
-
Limited cash reserves may force the company to seek unfavorable financing terms that could dilute shareholders
At $4.60 per share, Fluence Energy trades at 6.9x forward P/E. Read our free research report to see why you should think twice about including FLNC in your portfolio, it’s free.
Pediatrix Medical Group (MD)
Trailing 12-Month GAAP Operating Margin: -2.7%
With a network of approximately 2,620 affiliated physicians caring for some of the most vulnerable patients, Pediatrix Medical Group (NYSE:MD) provides specialized physician services focused on neonatal, maternal-fetal, pediatric cardiology and other pediatric subspecialty care across 37 states.
Why Is MD Risky?
-
Lagging comparable store sales over the past two years suggest it might have to change its pricing and marketing strategy to stimulate demand
-
Earnings per share fell by 11.7% annually over the last five years while its revenue grew, showing its incremental sales were much less profitable
-
Diminishing returns on capital from an already low starting point show that neither management’s prior nor current bets are going as planned